iCAD is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft System, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer.
Type
Public
HQ
Nashua, US
Employees
108 (est)-25%
icad is headquartered in Nashua, US

icad Locations

Nashua, US
San Jose, US

icad Metrics

icad Summary

Market capitalization

$56.3 M

Closing share price

$3.7
icad's latest market capitalization is $56.3 M.

icad Market Value History

icad Online Presence

icad Company Life

You may also be interested in